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Abstract Pyruvate dehydrogenase (E1p) is one of the compo-
nents of the pyruvate dehydrogenase multienzyme complex
(PDHC). Previously, it was shown that the N-terminal domain
of E1p is involved in its binding to the core component (E2p) of
PDHC. We constructed point mutations in this domain (D17Q,
D17R, E20Q, E20R, D24Q and D24R) to identify the speci¢c
residues involved in these interactions. Kinetic and binding stud-
ies show that D17 is essential for the binding of E1p to E2p.
D24 is involved in the binding, but not essential, whereas E20 is
not involved. None of the mutations a¡ects the folding or dimer-
isation of E1p. / 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
The pyruvate dehydrogenase multienzyme complex
(PDHC) from Gram-negative bacteria consists of multiple
copies of three di¡erent enzyme components: pyruvate dehy-
drogenase (E1p), dihydrolipoyl acyltransferase (E2p) and lip-
oamide dehydrogenase (E3). It catalyses the oxidative decar-
boxylation of pyruvate, resulting in the acetylation of coen-
zyme A and the transfer of reducing equivalents to NADþ
(for reviews see [1^5]).
From N- to C-terminus, E2p consists of two or three lipoyl
domains, each carrying a lipoyl-lysine group, an E1/E3 bind-
ing domain and a catalytic domain, which also forms the
structural core of the complex. Flexible alanine/proline rich
linkers of 20^40 amino acids interconnect these domains (for
reviews on E2 see [3,5]).
The E1 component exists both as a homodimer (K2) or a
heterotetramer (K2L2) depending on the source and type of
complex. Recently the three-dimensional structure of the het-
erotetrameric branched-chain oxoacid dehydrogenase (E1b)
from Pseudomonas putida and human and for homodimeric
E1p from Escherichia coli were solved [6^8] Moreover, recent
studies have given insight into the binding mode of homodi-
meric E1p from Azotobacter vinelandii ; limited proteolysis ex-
periments [9] and mutagenesis studies [10] showed that the
N-terminal region of E1p (amino acid 1^48) is essential for
it’s binding to E2p. Additionally, mutagenesis experiments of
E2p identi¢ed binding sites for E1p on both the E1/E3 bind-
ing domain of E2p and on the catalytic domain of E2p [11].
The construction of chimeric E2ps con¢rmed the importance
of both these domains in the interactions between E1p and
E2p [12]. For tight binding the homodimeric E1p requires two
N-terminal binding regions [10], therefore it seems likely that
one N-terminus of E1p interacts with the E1/E3 binding do-
main of E2p, whereas the other N-terminal region of E1p
binds to the catalytic domain of E2p. Structure and function
of the N-terminal region of E1p were studied in more detail
using a synthetic peptide representing this region and it was
shown that this region of E1p forms an independent folding
domain that speci¢cally competes with E1p for the binding to
E2p. CD and NMR measurements indicated that the N-ter-
minal domain is mostly K-helical [13]. These data combined
with a predicted secondary structure suggest that the domain
consists of a ‘helix^turn^helix’ motif, attached to the core of
E1 by an extended linker or loop. The £exibility of this N-ter-
minal domain is con¢rmed by the recently solved three-dimen-
sional structure of E. coli E1p [8], where no interpretable
electron density is observed for amino acids 1^55 Using an
amino acid sequence alignment of the N-terminal region of
E1p from several Gram-negative bacteria, combined with the
above, we have identi¢ed the residues D17, E20 and D24 in
the N-terminal domain to be likely candidates for the binding
of E1p to E2p. Additionally, these residues might be involved
in the species-speci¢c binding of E1p to E2p. Here we describe
a mutational analysis of these putative binding residues of
E1p.
2. Materials and methods
2.1. Construction of E1p mutants
The E1p mutants D17Q, D17R, E20Q, E20R, D24Q and D24R
were constructed using standard PCR mutagenesis techniques.
pAFH001 [9] was used as the wild-type template plasmid DNA.
2.2. Enzyme expression and puri¢cation
The E. coli strain TG2, a recA-version of TG1 [v(lac3proAB), thi,
supE, Res3 Mod3 (k), FP (traD36 proAþBþ, lacIq lacZ vM15)] [14]
harbouring the recombinant plasmid pAFH001, expressing wild-type
E1p was grown and puri¢ed as described in [9]. E1p mutants were
expressed and puri¢ed from E. coli as wild-type E1p to approximately
80% purity, omitting the gel ¢ltration and the second ion-exchange
chromatography step. The purity of the mutant E1ps was estimated
from their relative intensity on SDS^PAGE [19] coloured with Coo-
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massie stain. A. vinelandii wild-type E2p and E3 were expressed and
puri¢ed from E. coli TG2 as described in [15] and [16].
2.3. Enzyme activity assays
The oxidative decarboxylation of pyruvate by E1p was measured at
600 nm using 2,6-dichlorophenol-indophenol (Cl2Ind) (O=21.7U103
M31cm31) as an arti¢cial electron acceptor [17]. The overall PDHC
activity was reconstituted by incubating E2p with E1p or mutant E1p
and E3 and was measured spectrophotometrically at 340 nm as de-
scribed in [18]. Protein concentrations were estimated using the micro-
biuret method [20], Bovine serum albumin was used as a standard.
2.4. Interaction of E1p and E1p mutants with E2p
The binding of E1p or mutant E1p to E2p was analysed by ana-
lytical size-exclusion chromatography using a Superose 6 column
(Pharmacia Biotech) as described in [9].
3. Results and discussion
3.1. Kinetic characterisation of wild-type and mutant E1p
Based on a secondary structure prediction (Fig. 1) and on
experimental data showing that the N-terminal domain has a
high K-helical content, we previously proposed a ‘helix^turn^
helix’ motif for this domain [13] (Fig. 2). Mainly the N-ter-
minal K-helix has a very high content of acidic amino acid
residues. The interactions between E1p and E2p are highly
species-speci¢c, and it is therefore not likely that conserved
residues are solely involved in these interactions. Residues
D17, E20 and D24 of A. vinelandii E1p are not conserved
and moreover, the construction of a helical wheel of amino
acid residues 9^25 shows that they are all on the same side of
the helix. It therefore seems very likely that (some of) these
residues are involved in the interactions between E1p and
E2p. To test this hypothesis, we constructed the following
mutants of E1p: E1p-D17Q, E1p-D17R, E1p-E20Q, E1p-
E20R, E1p-D24Q and E1p-D24R.
Table 1 shows the kinetic parameters of these mutants and
of wild-type E1p. Clearly, the mutations D17R, E20Q, E20R
and D24Q have no signi¢cant e¡ects on the kinetic properties
of the enzyme. The mutations D17Q and D24R on the other
hand, do change the kinetics of the enzyme. Especially E1p-
D24R is strongly impaired in its E1-activity, whereas the e¡ect
on E1-D17Q is intermediate. Removal of amino acids 1^48
a¡ects the a⁄nity of E1p for pyruvate [10] and it is therefore
not entirely surprising that mutations in this region a¡ect the
kinetic parameters of E1p. From the structural and functional
information available at this time it is not possible to give an
explanation of this e¡ect. Results shown below prove however
that global misfolding of these mutants does not cause the
e¡ect on the activity of E1p-D24R and E1p-D17Q and there-
fore it is likely that the e¡ects on the catalytic activity of these
mutants is not directly correlated with their ability to interact
with E2p.
3.2. Binding properties of wild-type and mutant E1p
Two di¡erent methods were used to study the binding of
wild-type and mutant E1p to E2p. Firstly, PDHC was recon-
stituted by the addition of wild-type or mutant E1p to the
E2p/E3 sub-complex and PDHC activity was measured (Table
1, Fig. 3). Secondly, the binding properties of wild-type and
mutant E1p were studied by analytical gel ¢ltration (Table 1).
3.3. Binding studies by PDHC reconstitution
The ¢rst method shows that at an E1p:E2p ratio of 5:1
wild-type E1p virtually saturates E2p (based on the PDHC-
activity). E1p-E20Q and E1p-E20R also saturate E2p at this
ratio and consequently the residue E20 does not seem to be
involved in the interactions between E1p and E2p. Addition
of E1p-D17R, E1p-D17Q or E1p-D24R on the other hand,
results in only 1%, 28% or 10% of maximum PDHC activity
at a 5:1 E1p:E2p ratio (Table 1). The mutation D24Q has an
intermediate e¡ect on the PDHC activity at this ratio. At a
60-fold excess of E1p the PDHC activity of the severely af-
fected E1p mutants (E1p-D17R and E1p-D24R) reaches
about 50% of maximum PDHC activity. E1p-D17Q almost
saturates E2p at this ratio, whereas the mutant E1p-D24Q
attains saturation of E2p at 16-fold excess. Since at a 60-
fold excess of E1p the PDHC-activity curves of the severely
a¡ected E1p mutants do not reach saturation, but are still
increasing, it seems likely that at in¢nite mutant E1p concen-
trations saturation may occur.
Comparing the e¡ects of the mutations D17Q and D17R,
one sees that even though E1p-D17Q is quite impaired in its
E1 activity the mutation D17R (which has no e¡ect on the
E1-activity) has a stronger e¡ect on the complex activity.
Consequently, the impaired E1 activity of E1p-D17Q cannot
(fully) cause the decrease in complex activity. Similar consid-
erations are valid for E1p-D24R and E1p-D24Q; here it is
also likely that the e¡ect of E1p-D24Q on the complex activ-
ity is (at least partly) caused by e¡ects on the binding proper-
ties of this mutant.
3.4. Binding studies by analytical gel ¢ltration
Free A. vinelandii E2p forms a 24-meric cubic core structure
of about 1.5 MDa. Upon binding of wild-type E1p or E3 the
core dissociates into trimers with E1p or E3 bound (V400^
800 kDa). These two forms of E2p can be separated by gel
¢ltration chromatography [9] The results obtained by this
method (Table 1) correlate very well with the results that we
described above. The absence of dissociation of E2p by E1p-
D17Q, E1p-D17R or E1p-D24R is analogous to that observed
in Fig. 2 at ‘low’ (2:1) E1p:E2p ratio; no, or very low PDHC
activity is measured at this ratio using these mutants. These
experiments con¢rm that the low PDHC activities of E2p/E3
sub-complex recombined with either E1p-D17Q or E1p-D24R
Fig. 1. Sequence alignment of the N-terminal sequence of E1p from several Gram-negative bacteria. Entirely conserved negatively charged ami-
no acid residues are boxed and the mutated residues are shaded in grey. A. vin, A. vinelandii E1p; P. aer, P. aeruginosa E1p; A. eut, Alcali-
genes eutrophus E1p; N. men, Neisseria meningitidis E1p; E. coli, E. coli E1p; H. in£, Haemophilus in£uenzae E1p.
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are not caused by their decreased E1 activity, but (at least
partially) by a decreased binding a⁄nity for E2p. Even
though binding of E1p-D24Q to E2p results in dissociation
of E2p, a considerable fraction of E1p-D24Q remains un-
bound (data not shown), which correlates well with the inter-
mediate e¡ect that this mutant has on the complex activity as
was measured above.
The elution volumes of all six mutant E1ps are identical to
the elution volumes of wild-type E1p. This demonstrates that
none of the mutations a¡ects the folding or dimerisation of
E1p (as the molecular sizes of the mutants are not a¡ected).
This important observation shows that the observed e¡ects on
the activity and on the binding properties of these mutants are
not caused by misfolding of E1p. Dimerisation of E1p is cru-
cial for the binding of E1p to E2p and these results rule out
that e¡ects on the binding are caused by an indirect e¡ect via
an impaired dimerisation. Summarising, the above-described
measurements clearly establish that D17 is essential for the
binding of E1p to E2p. D24 on the other hand seems to be
involved in the interactions, but does not seem to be essential.
Mutation of the middle amino acid residue (E20) of the acidic
‘patch’ has no in£uence on the interactions of E1p to E2p.
This last observation indicates that the e¡ects on D17 and
D24 are speci¢c and not due to local misfolding.
3.5. Model of the binding mode of E1p to E2p
Using the above-described results we have re¢ned the model
of the binding mode of E1p and E2p that was postulated
before [13] (Fig. 2). A helical wheel of helix I of the proposed
‘helix^turn^helix’ motif (amino acids 9^25) shows that the
residues D17, E20 and D24 are on one side of the helix,
whereas on the opposite side W15, L19 and V22 form a hy-
drophobic ‘patch’. Helix II, of which it is less evident where it
starts and ¢nishes, also has a hydrophobic side, which can
form a hydrophobic ‘pocket’ with the residues of helix I. As
shown above, we have established that E20 is not involved in
interactions between E1p and E2p. D24 likely is (indirectly)
involved in the interactions between E1p and E2p, whereas
D17 is an essential binding residue. None of the mutations
result in complete abolishment of the binding capacity of E1p
to E2p; neither do point mutations in E2p [11]. Apparently
Fig. 2. A model of the N-terminal domain of E1p as inferred from
a secondary structure prediction and NMR, CD and £uorescence
spectroscopy data [13].
Fig. 3. A: Reconstitution of A. vinelandii PDHC using wild-type
E2p (3.9 WM) and E3 (2.8 WM) and either wild-type or mutant E1p.
E2p is pre-incubated with E3 at a molar ratio of 1:0.7 (E2p:E3).
Subsequently varying amounts of E1p are added to restore complex
activity. E1p-D17Q (7), E1p-D17R (E), E1p-E20Q (O), E1p-E20R
(U), E1p-D24Q (*), E1p-D24R (a) and wild-type E1p (b). B: Idem
at low E1/E2 chain ratios.
Table 1
Summary of the kinetic parameters for the E1-reaction by A. vinelandii E1p and A. vinelandii E1p mutants and the binding properties of wild-








[U mg E2p31 (% of control)]
E1p:E2p ratio 60:1
[U mg E2p31 (% of control)]
Dissociation
of E2p
E1p (wt) 24T7 55T 3 1.1T 0.1 40 (100) 45 (112)a yes
D17Q 24T8 20T 2 0.5T 0.2 11 (28) 38 (95) no
D17R 21T4 38T 1 1.0T 0.1 0.5 (1) 21 (53) no
E20Q 8T0.9 58T 1 1.2T 0.1 33 (83) 32 (80) yes
E20R 20T3 90T 3 0.9T 0.1 43 (107) 43 (107) yes
D24Q 21T5 63T 3 1.0T 0.1 26 (65) 40 (100)a yes
D24R 14T3 11T 0.4 ND 4 (10) 17 (43) no
S0:5 and Vmax values are calculated from V vs. [S] curves. The Hill coe⁄cients are calculated from log([S]) vs. log((Vmax3v)/v) curves. The activ-
ities of pyruvate dehydrogenase complexes containing wild-type E2p and E3 from A. vinelandii and wild-type or mutant E1p are shown at an
E1p:E2p ratio of 5:1 and 60:1. The reactions were performed as described in the experimental procedures. ND, not determined.
aDetermined at a E1p:E2p ratio of 16:1.
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the binding interface is composed of more than one region
both on E2p (binding domain and catalytic domain) and on
E1p.
3.6. Species speci¢city
Not only from their proposed location in the ¢rst helix of
the N-terminal domain, but also based on species di¡erences,
it seems likely that D17, E20 or D24 is involved in the binding
of E1p to E2p. Previously, it was shown that the binding of
E1p to E2p is highly species-speci¢c [12]. Based on this, it
seems likely that the binding residues in the N-terminal bind-
ing domain of E1p are not entirely conserved, i.e. di¡erence
between species should be observed. Whereas the surrounding
acidic residues (E11, E14 and E26) are highly conserved, D17,
E20 and D24 of A. vinelandii E1p exhibit di¡erences with
some of the other species (Fig. 1). In E. coli E1p these residues
are Q17, E20 and R24. Previously, it was shown, using chi-
meras of E. coli and A. vinelandii E2p that E. coli E1p solely
binds to E. coli E2p and not at all to A. vinelandii E2p. Bind-
ing, on the other hand, of, visa versa, A. vinelandii E1p to
E. coli E2p still results in 60% residual PDHC activity. Testing
the reverse e¡ect (whether the mutations D17Q and D24R
result in an increased binding to E. coli E2p) is extremely
di⁄cult, as it would require E. coli E2p that contains abso-
lutely no E. coli E1p. The fact that the mutations D17Q and
D24R both have such a strong e¡ect on the binding abilities
of E1p nevertheless correlates well with the fact that E. coli
E1p binds very poorly to A. vinelandii E2p.
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